Found 109 hits of Enzyme Inhibition Constant Data
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 103nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 129nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 145nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 175nMAssay Description:Inhibition of EML4-ALK tyrosine phosphorylation in human NCI-H2228 cellsMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISAMore data for this Ligand-Target Pair
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISAMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 382nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 403nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 435nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 508nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 662nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 722nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 736nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 814nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 915nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetFocal adhesion kinase 1(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 944nMAssay Description:Inhibition of FAK phosphorylation in human HCC827 cells after 2 to 2.5 hrs by immunoblot analysisMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 994nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.76E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of recombinant human INSR expressed in baculovirus using ATP as substrate after 15 mins by TRF assayMore data for this Ligand-Target Pair
TargetInsulin receptor(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of INSR (unknown origin) by cell based assayMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 2.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 3.70E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 9.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2D6 in human liver microsomes using dextromethorphan as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP3A4 in human liver microsomes using testosterone/midazolam as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP1A2 in human liver microsomes using phenacetin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C19 in human liver microsomes using S-mephenytoin as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Homo sapiens (Human))
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Teva Branded Pharmaceutical Products R&D
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate in presence of NADPH by LC/MS/MS analysisMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)